BRIEF: Xuanzhu Biopharma launches IPO to raise $100 million
Xuanzhu Biopharmaceutical Co., Ltd. (2575.HK), spun off from Sihuan Pharma (0460.HK), launched its IPO on Monday, aiming to sell 67.3 million shares for HK$11.60 each to raise HK$780 million ($100…
Recent Articles
RELATED ARTICLES
-
BRIEF: Shuangdeng launches Hong Kong IPO to raise $118 million
6960.HK - BRIEF: Newtrend launches Hong Kong IPO to raise up to $31 million
-
BRIEF: Hipine launches Hong Kong IPO to raise up to $44 million
2583.HK
-
BRIEF: CF PharmTech to raise $77 million in Hong Kong IPO
2652.HK
- Anti-toxin provider Jiangxi Institute joins biopharma IPO rush
- BRIEF: Innogen launches $87 million Hong Kong IPO
-
BRIEF: Cloudbreak launches $78 million Hong Kong IPO
2592.HK
